Mama, Bb Girl .
HRN: 27-08-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/08/2025
05/15/2025
IVTT
42mg
Q24hours
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes